Following approval by ANMAT, the Japanese laboratory will establish the protocols for starting the production process. This is for the shipment of a batch of the dengue vaccine to Argentina.
Climate change is having a massive global impact on dengue transmission, accounting for 19% of the current dengue burden, with a potential to spark an ...
The drug, produced by the laboratory Takeda, targets “dengue virus 2” and protects against the four viruses that transmit the disease, it was also explained after the National Administration ...
The Shresta laboratory (Sujan Shresta, Stuart Perry and Michael Buck) receives some financial support for research from private sector entities that are developing dengue therapeutics (Conatus ...